AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $166,570 | +20.1% | 56,369 | -4.9% | 0.00% | – |
| Q1 2023 | $138,711 | -42.9% | 59,278 | -50.2% | 0.00% | – |
| Q4 2022 | $242,882 | +29.9% | 119,060 | +100.9% | 0.00% | – |
| Q3 2022 | $187,000 | -11.0% | 59,275 | +1.7% | 0.00% | – |
| Q2 2022 | $210,000 | -10.6% | 58,261 | -0.9% | 0.00% | – |
| Q1 2022 | $235,000 | -15.5% | 58,768 | +4.5% | 0.00% | – |
| Q4 2021 | $278,000 | -25.1% | 56,238 | +1.8% | 0.00% | – |
| Q3 2021 | $371,000 | +68.6% | 55,238 | +99.4% | 0.00% | – |
| Q2 2021 | $220,000 | +2.3% | 27,709 | -2.1% | 0.00% | – |
| Q1 2021 | $215,000 | +47.3% | 28,314 | 0.0% | 0.00% | – |
| Q4 2020 | $146,000 | +2.8% | 28,314 | -2.9% | 0.00% | – |
| Q3 2020 | $142,000 | -30.4% | 29,161 | -3.6% | 0.00% | – |
| Q2 2020 | $204,000 | -1.0% | 30,241 | +1.5% | 0.00% | – |
| Q1 2020 | $206,000 | -24.3% | 29,793 | -6.8% | 0.00% | – |
| Q4 2019 | $272,000 | +68.9% | 31,959 | -1.5% | 0.00% | – |
| Q3 2019 | $161,000 | -10.6% | 32,439 | 0.0% | 0.00% | – |
| Q2 2019 | $180,000 | +9.8% | 32,439 | 0.0% | 0.00% | – |
| Q1 2019 | $164,000 | -48.1% | 32,439 | -2.9% | 0.00% | – |
| Q4 2018 | $316,000 | +26.4% | 33,418 | +6.8% | 0.00% | – |
| Q3 2018 | $250,000 | – | 31,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
| Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
| PA Capital LLC | 76,257 | $377,000 | 0.37% |
| Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
| COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
| Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
| Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
| APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |